Jeffrey A. Singer is a senior fellow at Reason Foundation, where he focuses on health care policy and drug policy.
He is President Emeritus and founder of Valley Surgical Clinics, Ltd., Arizona's oldest and largest private group surgical practice. From 2017 to 2026, he served as a senior fellow in the Cato Institute's Department of Health Policy Studies and as a Visiting Fellow at the Goldwater Institute. Singer is a member of the Board of Scientific Advisors of the American Council on Science and Health and serves on the expert panel for Doctors for Drug Policy Reform. From 1994 to 2016, he was a regular contributor to Arizona Medicine, the journal of the Arizona Medical Association. He served on the Advisory Board Council of the Center for Political Thought and Leadership at Arizona State University from 2014 to 2018. His writings have appeared in peer-reviewed medical and scientific journals, as well as in publications such as the Wall Street Journal, Washington Post, USA Today, The Hill, and National Review. He has been a guest on national and local television and radio. Singer received his BA from Brooklyn College (City University of New York) and his MD from New York Medical College. He is a Fellow of the American College of Surgeons.
-
Women should have easier access to menopause treatment
Removing prescription barriers and expanding pharmacists’ prescribing authority would give women easier access to menopause treatment.
-
RFK Jr. is right to expand consumer access to peptides
Allowing pharmacies to compound experimental peptides would give consumers a more accountable alternative to unregulated sellers.
-
Accept treatment or lose access: Ontario’s new opioid rules undermine harm reduction
Restricting access to pharmaceutical opioids risks driving patients back to the dangerous illicit market these programs seek to help them avoid.
-
Abolish the Surgeon General’s office and its 6,000-person bureaucracy
The federal government needs public health professionals, not a separate uniformed bureaucracy to employ them.
-
The toxicology report on 2 dead students isn’t back. But the Kratom panic is already here
Before the science is in, the panic is already writing policy.
-
Patients have a right to try. Why can’t they use it?
Terminally ill patients were promised access to experimental treatments, but the "right to try" exists mostly on paper.
-
America has gone more than a year without a Surgeon General. Has anyone noticed?
Rather than debating over who should fill the role, Congress and the White House should just eliminate it altogether.
-
The feds are investing in wearable health trackers. That could put your private data at risk
Government-backed biowearables could generate vast streams of personal health data with few legal safeguards.
-
FDA commissioner says ‘Everything should be over the counter.’ Don’t count on big pharma to lead the way
A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost.
-
Drug Legalization Handbook
"America needs to recognize that we will not see a reduction in violent crimes until we legalize drugs. All drugs."
-
A Physician’s Take on the “Death Panel” Revelation
The truth about end-of-life counseling
-
A Simple Way to Improve Medicare
End the "doc fix" and allow balance-billing
